Antihypertensive 1,4-Dihydropyridines as Correctors of the Cystic Fibrosis Transmembrane Conductance Regulator Channel Gating Defect Caused by Cystic Fibrosis Mutations-Reference-Cited by-同舟云学术

Antihypertensive 1,4-Dihydropyridines as Correctors of the Cystic Fibrosis Transmembrane Conductance Regulator Channel Gating Defect Caused by Cystic Fibrosis Mutations

Published:2005-09-08 Issue:6 Volume:68 Page:1736-1746
ISSN:0026-895X
Container-title:Molecular Pharmacology
language:en
Short-container-title:Mol Pharmacol

Author:

Pedemonte Nicoletta,Diena Tullia,Caci Emanuela,Nieddu Erika,Mazzei Mauro,Ravazzolo Roberto,Zegarra-Moran Olga,Galietta Luis J. V.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference38 articles.

1. Effects of the Enantiomers of BayK 8644 on the Charge Movement of L-type Ca Channels in Guinea-pig Ventricular Myocytes

2. Characterization of the Dexniguldipine Binding Site in the Multidrug Resistance-Related Transport Protein P-Glycoprotein by Photoaffinity Labeling and Mass Spectrometry

3. Altered chloride ion channel kinetics associated with the ΔF508 cystic fibrosis mutation

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overview of CFTR activators and their recent studies for dry eye disease: a review;RSC Medicinal Chemistry;2023

2. Using the genome to correct the ion transport defect in cystic fibrosis;The Journal of Physiology;2022-09-30

3. Effects of Antihypertensive Drugs on Thyroid Function in Type 2 Diabetes Patients With Euthyroidism;Frontiers in Pharmacology;2022-03-07

4. Ethical Dilemma;Chest;2021-09

5. A Systematic Review on 1, 4-Dihydropyridines and its Analogues: An Elite Scaffold;Biointerface Research in Applied Chemistry;2021-08-08